Glycemic variability assessed by continuous glucose monitoring in hospitalized patients with community-acquired pneumonia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2466
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Glycemic variability assessed by continuous glucose monitoring in hospitalized patients with community-acquired pneumonia ; volume:22 ; number:1 ; day:9 ; month:3 ; year:2022 ; pages:1-13 ; date:12.2022
BMC pulmonary medicine ; 22, Heft 1 (9.3.2022), 1-13, 12.2022
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Olsen, Mikkel Thor
Dungu, Arnold Matovu
Klarskov, Carina Kirstine
Jensen, Andreas Kryger
Lindegaard, Birgitte
Kristensen, Peter Lommer
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12890-022-01874-7
- URN
-
urn:nbn:de:101:1-2022060411292449656996
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Olsen, Mikkel Thor
- Dungu, Arnold Matovu
- Klarskov, Carina Kirstine
- Jensen, Andreas Kryger
- Lindegaard, Birgitte
- Kristensen, Peter Lommer
- SpringerLink (Online service)
Ähnliche Objekte (12)
Community-Acquired Infection among the Hospitalized Renal Stone Patients
Cardiovascular autonomic alterations in hospitalized patients with community-acquired pneumonia
Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective
Switch therapy in hospitalized patients with community-acquired pneumonia: Tigecycline vs. Levofloxacin
Childhood community-acquired pneumonia
Clinical characteristics of hospitalized term and preterm infants with community-acquired viral pneumonia
Etiologic spectrum and occurrence of coinfections in children hospitalized with community-acquired pneumonia
Community-acquired and hospital-acquired respiratory tract infection and bloodstream infection in patients hospitalized with COVID-19 pneumonia
Correction to: Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective
Serum Leptin in Hospitalized Community-Acquired Pneumonia Children under the Age of Five Years
Age-specific risk factors of severe pneumonia among pediatric patients hospitalized with community-acquired pneumonia
Children hospitalized with community-acquired pneumonia complicated by effusion: a single-centre retrospective cohort study
Community-Acquired Infection among the Hospitalized Renal Stone Patients
Cardiovascular autonomic alterations in hospitalized patients with community-acquired pneumonia
Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective
Switch therapy in hospitalized patients with community-acquired pneumonia: Tigecycline vs. Levofloxacin
Childhood community-acquired pneumonia
Clinical characteristics of hospitalized term and preterm infants with community-acquired viral pneumonia
Etiologic spectrum and occurrence of coinfections in children hospitalized with community-acquired pneumonia
Community-acquired and hospital-acquired respiratory tract infection and bloodstream infection in patients hospitalized with COVID-19 pneumonia
Correction to: Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective
Serum Leptin in Hospitalized Community-Acquired Pneumonia Children under the Age of Five Years
Age-specific risk factors of severe pneumonia among pediatric patients hospitalized with community-acquired pneumonia
Children hospitalized with community-acquired pneumonia complicated by effusion: a single-centre retrospective cohort study
Community-Acquired Infection among the Hospitalized Renal Stone Patients
Cardiovascular autonomic alterations in hospitalized patients with community-acquired pneumonia
Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective
Switch therapy in hospitalized patients with community-acquired pneumonia: Tigecycline vs. Levofloxacin
Childhood community-acquired pneumonia
Clinical characteristics of hospitalized term and preterm infants with community-acquired viral pneumonia
Etiologic spectrum and occurrence of coinfections in children hospitalized with community-acquired pneumonia
Community-acquired and hospital-acquired respiratory tract infection and bloodstream infection in patients hospitalized with COVID-19 pneumonia
Correction to: Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective
Serum Leptin in Hospitalized Community-Acquired Pneumonia Children under the Age of Five Years
Age-specific risk factors of severe pneumonia among pediatric patients hospitalized with community-acquired pneumonia